» Articles » PMID: 37822916

Supramolecular Self-assembly of EGCG-selenomethionine Nanodrug for Treating Osteoarthritis

Overview
Journal Bioact Mater
Date 2023 Oct 12
PMID 37822916
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) has emerged as a significant health concern among the elderly population, with increasing attention paid to ferroptosis-induced OA in recent years. However, the prolonged use of nonsteroidal anti-inflammatory drugs or corticosteroids can lead to a series of side effects and limited therapeutic efficacy. This study aimed to employ the Mannich condensation reaction between epigallocatechin-3-gallate (EGCG) and selenomethionine (SeMet) to efficiently synthesize polyphenol-based nanodrugs in aqueous media for treating OA. Molecular biology experiments demonstrated that EGCG-based nanodrugs (ES NDs) could effectively reduce glutathione peroxidase 4 (GPX4) inactivation, abnormal Fe accumulation, and lipid peroxidation induced by oxidative stress, which ameliorated the metabolic disorder of chondrocytes and other multiple pathological processes triggered by ferroptosis. Moreover, imaging and histopathological analysis of the destabilization of the medial meniscus model in mice confirmed that ES NDs exhibiting significant therapeutic effects in relieving OA. The intra-articular delivery of ES NDs represents a promising approach for treating OA and other joint inflammatory diseases.

Citing Articles

Cell-free osteoarthritis treatment with dual-engineered chondrocyte-targeted extracellular vesicles derived from mechanical loading primed mesenchymal stem cells.

Wang P, Zhao H, Chen W, Guo Y, Zhang S, Xing X J Tissue Eng. 2025; 16:20417314241312563.

PMID: 39926048 PMC: 11806476. DOI: 10.1177/20417314241312563.


EGCG activates Keap1/P62/Nrf2 pathway, inhibits iron deposition and apoptosis in rats with cerebral hemorrhage.

Hao L, Zhang A, Lv D, Cong L, Sun Z, Liu L Sci Rep. 2024; 14(1):31474.

PMID: 39732956 PMC: 11682079. DOI: 10.1038/s41598-024-82938-y.


Ultra-Long-Term Anti-Inflammatory Polyphenol Capsule to Remodel the Microenvironment for Accelerating Osteoarthritis Healing by Single Dosage.

Wei S, Shou Z, Yang D, Sun L, Guo Y, Wang Y Adv Sci (Weinh). 2024; 11(48):e2407425.

PMID: 39556697 PMC: 11672291. DOI: 10.1002/advs.202407425.


Ferroptosis in Osteoarthritis: Current Understanding.

Liu Y, Zhang Z, Fang Y, Liu C, Zhang H J Inflamm Res. 2024; 17:8471-8486.

PMID: 39529997 PMC: 11552513. DOI: 10.2147/JIR.S493001.


Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota.

Hridayanka K, Duttaroy A, Basak S Nutrients. 2024; 16(21).

PMID: 39519419 PMC: 11547880. DOI: 10.3390/nu16213587.


References
1.
Chang R, Zhao L, Xing R, Li J, Yan X . Functional chromopeptide nanoarchitectonics: molecular design, self-assembly and biological applications. Chem Soc Rev. 2023; 52(8):2688-2712. DOI: 10.1039/d2cs00675h. View

2.
Seo Y, Sweeney C, Smith M . Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene. 2002; 21(23):3663-9. DOI: 10.1038/sj.onc.1205468. View

3.
Zheng J, Conrad M . The Metabolic Underpinnings of Ferroptosis. Cell Metab. 2020; 32(6):920-937. DOI: 10.1016/j.cmet.2020.10.011. View

4.
Li H, Xiang D, Gong C, Wang X, Liu L . Naturally derived injectable hydrogels with ROS-scavenging property to protect transplanted stem cell bioactivity for osteoarthritic cartilage repair. Front Bioeng Biotechnol. 2023; 10:1109074. PMC: 9848398. DOI: 10.3389/fbioe.2022.1109074. View

5.
Seibt T, Proneth B, Conrad M . Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2018; 133:144-152. DOI: 10.1016/j.freeradbiomed.2018.09.014. View